EA200401084A1 - Способ местного применения дапсона для лечения угревой сыпи - Google Patents

Способ местного применения дапсона для лечения угревой сыпи

Info

Publication number
EA200401084A1
EA200401084A1 EA200401084A EA200401084A EA200401084A1 EA 200401084 A1 EA200401084 A1 EA 200401084A1 EA 200401084 A EA200401084 A EA 200401084A EA 200401084 A EA200401084 A EA 200401084A EA 200401084 A1 EA200401084 A1 EA 200401084A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dapson
treatment
local application
oxidative chemical
composition
Prior art date
Application number
EA200401084A
Other languages
English (en)
Other versions
EA008022B1 (ru
Inventor
Девид Озборн
Original Assignee
Атрикс Леборетериз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Атрикс Леборетериз, Инк. filed Critical Атрикс Леборетериз, Инк.
Publication of EA200401084A1 publication Critical patent/EA200401084A1/ru
Publication of EA008022B1 publication Critical patent/EA008022B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Floor Finish (AREA)

Abstract

Настоящее изобретение относится к способу лечения угревой сыпи путем местного нанесения дерматологического состава, содержащего дапсон. Помимо поражений воспалительного характера указанными составами лечат и невоспалительную угревую сыпь. Состав подобран таким образом, что содержит дапсон в растворенном состоянии и в виде микрочастиц.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401084A 2002-02-20 2002-03-18 Способ местного применения дапсона для лечения угревой сыпи EA008022B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/081,050 US20030157036A1 (en) 2002-02-20 2002-02-20 Topical dapsone for the treatment of acne
PCT/US2002/008449 WO2003072071A1 (en) 2002-02-20 2002-03-18 Topical dapsone for the treatment of acne

Publications (2)

Publication Number Publication Date
EA200401084A1 true EA200401084A1 (ru) 2005-08-25
EA008022B1 EA008022B1 (ru) 2007-02-27

Family

ID=27733245

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401084A EA008022B1 (ru) 2002-02-20 2002-03-18 Способ местного применения дапсона для лечения угревой сыпи

Country Status (23)

Country Link
US (2) US20030157036A1 (ru)
EP (1) EP1485059B1 (ru)
JP (1) JP2005524651A (ru)
KR (1) KR100864129B1 (ru)
CN (1) CN1625384A (ru)
AT (1) ATE353628T1 (ru)
AU (1) AU2002306767B2 (ru)
BR (1) BR0215606A (ru)
CA (3) CA2855045A1 (ru)
DE (1) DE60218227T2 (ru)
DK (1) DK1485059T3 (ru)
EA (1) EA008022B1 (ru)
ES (1) ES2280629T3 (ru)
HK (1) HK1072010A1 (ru)
IL (1) IL163650A0 (ru)
IS (1) IS2454B (ru)
MX (1) MXPA02006593A (ru)
NO (1) NO20043877L (ru)
NZ (1) NZ535363A (ru)
PT (1) PT1485059E (ru)
SI (1) SI1485059T1 (ru)
WO (1) WO2003072071A1 (ru)
ZA (1) ZA200407439B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097030A1 (en) * 2002-05-21 2003-11-27 Immune Network Ltd. Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
JP2007533606A (ja) * 2003-08-13 2007-11-22 キューエルティー・ユーエスエイ・インコーポレーテッド ダプソンを含む乳化組成物
US20060286108A1 (en) * 2005-06-16 2006-12-21 Bell Katherine A Topical compositions for the treatment of chronic wounds
KR100806051B1 (ko) 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
EP2139444A2 (en) * 2007-03-21 2010-01-06 Dow Global Technologies Inc. Sustained-release composition
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
US20110294896A1 (en) * 2007-11-07 2011-12-01 Garret John S Topical Treatment With Dapsone In G6PD-Deficient Patients
WO2009108147A1 (en) * 2008-02-27 2009-09-03 Qlt Usa, Inc. Dapsone to treat rosascea
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
JP2013500984A (ja) * 2009-07-30 2013-01-10 アラーガン、インコーポレイテッド ダプソンとアダパレンの組み合わせ
CN103054792B (zh) * 2011-10-21 2017-06-06 重庆华邦制药有限公司 一种质量稳定的氨苯砜凝胶及其制备方法
KR20130063962A (ko) * 2011-12-07 2013-06-17 가천대학교 산학협력단 디아미노디페닐술폰을 포함하는 골량 저하 질환의 예방 또는 치료용 약학적 조성물
EP2922528B1 (en) 2012-11-20 2017-05-31 Allergan, Inc. Topical dapsone and dapsone/adapalene compositions and methods for use thereof
WO2016019336A1 (en) * 2014-07-31 2016-02-04 Allergan, Inc. Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
AU2016348527A1 (en) * 2015-11-04 2018-05-24 Allergan, Inc. Methods of treatment of acne vulgaris using topical dapsone compositions
CN115887357B (zh) * 2022-11-28 2023-07-11 哈尔滨葵花药业有限公司 氨苯砜凝胶制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419009A1 (de) * 1984-05-22 1985-11-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
US20040086469A1 (en) * 2002-10-30 2004-05-06 Osborne David W. Protectant for UV-induced skin damage

Also Published As

Publication number Publication date
KR20040085214A (ko) 2004-10-07
NO20043877L (no) 2004-09-15
DE60218227T2 (de) 2007-10-31
NZ535363A (en) 2007-04-27
HK1072010A1 (en) 2005-08-12
CA2855045A1 (en) 2003-09-04
IL163650A0 (en) 2005-12-18
EA008022B1 (ru) 2007-02-27
CA2477217C (en) 2012-07-17
EP1485059A4 (en) 2005-09-21
SI1485059T1 (sl) 2007-06-30
US20070122435A1 (en) 2007-05-31
DE60218227D1 (de) 2007-03-29
EP1485059B1 (en) 2007-02-14
ES2280629T3 (es) 2007-09-16
WO2003072071A1 (en) 2003-09-04
PT1485059E (pt) 2007-04-30
CA2776702C (en) 2014-09-02
EP1485059A1 (en) 2004-12-15
CN1625384A (zh) 2005-06-08
BR0215606A (pt) 2004-12-07
ZA200407439B (en) 2006-06-28
AU2002306767B2 (en) 2007-09-13
MXPA02006593A (es) 2004-08-19
KR100864129B1 (ko) 2008-10-16
CA2776702A1 (en) 2003-09-04
JP2005524651A (ja) 2005-08-18
DK1485059T3 (da) 2007-05-07
AU2002306767B9 (en) 2003-09-09
AU2002306767A1 (en) 2003-09-09
US20030157036A1 (en) 2003-08-21
IS7419A (is) 2004-08-20
CA2477217A1 (en) 2003-09-04
ATE353628T1 (de) 2007-03-15
IS2454B (is) 2008-11-15

Similar Documents

Publication Publication Date Title
HK1072010A1 (en) Topical dapsone for the treatment of acne
NO20061950L (no) Benzoimidazolforbindelser
CY1106604T1 (el) Μεθοδος αντιμετωπισης της κοινης ακμης με τη χρηση σκευασματος αβερμεκτινης
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
ATE432338T1 (de) Alanin-2,3-aminomutase
HK1093678A1 (en) Cosmetic composition containing nicotinamide and self tanning agent for use as self tanning composition
NO20031192L (no) Isoksazoler og deres anvendelse som inhibitorer av ERK
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
TW200510397A (en) Conjugated complement cascade inhibitors
NO20061277L (no) Farmasoytiske sammensetninger omfattende malonamidderivater for redusering av sebum produksjon
WO2007024574A3 (en) Topical formulations of histone deacetylase inhibitors and methods of using the same
TW200513271A (en) Topical treatment of skin conditions
HK1059439A1 (en) Compounds having activity as inhibitors of cytochrome p450rai
WO2007106622A3 (en) Fungicidal formulation and method of use
TW200505473A (en) Compositions and methods for treatment of psoriasis
WO2005066116A8 (en) Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
ATE247947T1 (de) Verfahren und zusammensetzung zur behandlung von akne
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
SE0100326D0 (sv) New compounds
BRPI0410358A (pt) tratamento tópico de condições da pele
ATE554757T1 (de) Verwendung von mindestens einem 2-alkyl-furan als wirkstoff zur depigmentierung oder aufhellung
ATE345117T1 (de) Biphenylverbindungen sowie ihre anwendung als östrogene mittel
ATE206052T1 (de) Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
AP1777A (en) Use of topical compositions for the control of microbial diseases of the nail.
WO2002041832A8 (en) Compositions having comfrey and methods for reducing retinoid-induced skin irritation

Legal Events

Date Code Title Description
PD1A Registration of transfer to a eurasian application by order of succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU